Cornelis (Cox) Pieter Terhorst

Affiliations:

Immunology

Harvard Medical School, Boston, MA, United States

Website:

http://www.hms.harvard.edu/dms/immunology/fac/Terhorst.php

Google:

"Cornelis Pieter Terhorst"

Bio:

http://www.bidmc.org/~/media/Files/Centers%20and%20Departments/Medicine/Annual%20Report%20PDFs/2015InteractiveReport_Hi.pdf Cox Terhorst, PhD, Chief of the Division of Immunology, received his doctorate in Molecular Biology from the University of Leiden in the Netherlands. His work there with the late Wim Möller, PhD, was on the ribosomal proteins L7/L12, which are docking sites for GTPase factors involved in protein synthesis.
Terhorst then did his post-doctoral work on HLA proteins at Harvard University under the mentorship of Jack Strominger, MD.
DOI: 10.1016/0014-5793(70)80261-7

Mean distance: (not calculated yet)

Tree Publications Similar researchers PubMed Report error

Parents

Wilhelmus (Wim) Johannes Hubertus Maria Möller	grad student	1973	Leiden
(Structural studies on a 50S ribosomal protein involved in the hydrolysis of guanosine 5'-triphosphate.)
Jack L. Strominger	post-doc		Harvard

Children

Hans (Johannes Carolus) Clevers	post-doc	1986-1989	Harvard Medical School (GenetiTree)
Paul Alan Bleicher	post-doc	1987-1990	Dana Farber Cancer Institute, Harvard Medical School

Collaborators

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Bertolini TB, Herzog RW, Kumar SRP, et al. (2023) Suppression of anti-drug antibody formation against coagulation factor VIII by oral delivery of anti-CD3 monoclonal antibody in hemophilia A mice. Cellular Immunology. 385: 104675
Shirley JL, Keeler GD, Sherman A, et al. (2019) Type I IFN Sensing by cDCs and CD4 T Cell Help Are Both Requisite for Cross-Priming of AAV Capsid-Specific CD8 T Cells. Molecular Therapy : the Journal of the American Society of Gene Therapy
Yigit B, Wang N, Ten Hacken E, et al. (2019) SLAMF6 as a regulator of exhausted CD8+ T cells in cancer. Cancer Immunology Research
Herzog RW, Kuteyeva V, Saboungi R, et al. (2019) Reprogrammed CD4 T Cells That Express FoxP3 Control Inhibitory Antibody Formation in Hemophilia A Mice. Frontiers in Immunology. 10: 274
Chen CW, Mittal R, Klingensmith NJ, et al. (2017) Cutting Edge: 2B4-Mediated Coinhibition of CD4(+) T Cells Underlies Mortality in Experimental Sepsis. Journal of Immunology (Baltimore, Md. : 1950)
Rogers GL, Shirley JL, Zolotukhin I, et al. (2017) Plasmacytoid and conventional dendritic cells cooperate in crosspriming AAV capsid-specific CD8(+) T cells. Blood. 129: 3184-3195
Perrin GQ, Zolotukhin I, Sherman A, et al. (2016) Dynamics of antigen presentation to transgene product-specific CD4(+) T cells and of Treg induction upon hepatic AAV gene transfer. Molecular Therapy. Methods & Clinical Development. 3: 16083
Wang N, Keszei M, Halibozek P, et al. (2016) Slamf6 negatively regulates autoimmunity. Clinical Immunology (Orlando, Fla.)
Chaudhary A, Leite M, Kulasekara BR, et al. (2016) Human Diversity in a Cell Surface Receptor that Inhibits Autophagy. Current Biology : Cb
McArdel SL, Terhorst C, Sharpe AH. (2016) Roles of CD48 in regulating immunity and tolerance. Clinical Immunology (Orlando, Fla.). 164: 10-20